Home LiteratureArticle Details
PMID: 1281207 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes.

The Journal of experimental medicine ·Vol. 176 ·No. 6 ·1992-12-01 ·Pages 1489-95

Rot A, Krieger M, Brunner T, Bischoff SC, Schall TJ, Dahinden CA

Abstract

The cellular infiltrates of certain inflammatory processes found in parasitic infection or in allergic diseases consist predominantly of eosinophilic granulocytes, often in association with activated T cells. This suggests the existence of chemotactic agonists specific for eosinophils and lymphocyte subsets devoid of neutrophil-activating properties. We therefore examined four members of the intercrine/chemokine superfamily of cytokines (monocyte chemotactic peptide 1 [MCP-1], RANTES, macrophage inflammatory protein 1 alpha [MIP-1 alpha], and MIP-1 beta), which do not activate neutrophils, for their ability to affect different eosinophil effector functions. RANTES strongly attracted normal human eosinophils by a chemotactic rather than a chemokinetic mechanism with a similar efficacy as the most potent chemotactic myeloid cell agonist, C5a. MIP-1 alpha also induced eosinophil migration, however, with lower efficacy. RANTES and MIP-1 alpha induced eosinophil cationic protein release in cytochalasin B-treated eosinophils, but did not promote leukotriene C4 formation by eosinophils, even after preincubation with interleukin 3 (IL-3), in contrast to other chemotactic agonists such as C5a and formyl-methionyl-leucyl-phenylalanine (FMLP). RANTES, but not MIP-1 alpha, induced a biphasic chemiluminescence response, however, of lower magnitude than C5a. RANTES and MIP-1 alpha both promoted identical transient changes in intracellular free calcium concentration ([Ca2+]i), with kinetics similar to those induced by chemotactic peptides known to interact with G protein-coupled receptors. No cross-desensitization towards other peptide agonists (e.g., C5a, IL-8, FMLP) was observed, suggesting the presence of specific receptors. Despite its weaker eosinophil-activating properties, MIP-1 alpha was at least 10 times more potent on a molar basis than RANTES at inducing [Ca2+]i changes. Interestingly, RANTES deactivated the MIP-1 alpha-induced [Ca2+]i changes, while the RANTES response was preserved after MIP-1 alpha stimulation. MCP-1, a potent monocyte chemoattractant and basophil agonist, as well as MIP-1 beta, a peptide with pronounced homology to MIP-1 alpha, did not activate the eosinophil functions tested. Our results indicate that RANTES and MIP-1 alpha are crucial mediators of inflammatory processes in which eosinophils predominate.

MeSH Terms
Blood Proteins/biosynthesis Chemokine CCL3 Chemokine CCL4 Chemokine CCL5 Chemotaxis, Leukocyte/drug effects Complement C5a/pharmacology Cytokines/pharmacology Eosinophil Granule Proteins Eosinophils/drug effects,physiology Escherichia coli/genetics Humans In Vitro Techniques Kinetics Luminescent Measurements Lymphokines/pharmacology Macrophage Inflammatory Proteins Monokines/pharmacology N-Formylmethionine Leucyl-Phenylalanine/pharmacology Recombinant Proteins/pharmacology Ribonucleases SRS-A/biosynthesis,blood Superoxides/blood
Chemicals
Blood Proteins Chemokine CCL3 Chemokine CCL4 Chemokine CCL5 Cytokines Eosinophil Granule Proteins Lymphokines Macrophage Inflammatory Proteins Monokines Recombinant Proteins SRS-A Superoxides N-Formylmethionine Leucyl-Phenylalanine Complement C5a Ribonucleases
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Rot A
Institute of Clinical Immunology, Bern, Switzerland.
Krieger M
Brunner T
Bischoff S C
Schall T J
Dahinden C A
References (27)
27 references, click to expand
  1. Identification of high affinity receptors for human monocyte chemoattractant protein-1 on human monocytes.
    J Immunol. 1990 Jul 1;145(1):292-7 PMID: 2162890
  2. Shape changes, exocytosis, and cytosolic free calcium changes in stimulated human eosinophils.
    J Clin Invest. 1991 Jun;87(6):2012-7 PMID: 2040692
  3. Neutrophil-activating properties of the melanoma growth-stimulatory activity.
    J Exp Med. 1990 May 1;171(5):1797-802 PMID: 2185333
  4. Human monocyte chemoattractant protein-1 (MCP-1).
    Immunol Today. 1990 Mar;11(3):97-101 PMID: 2186747
  5. Leukocyte specificity and binding of human neutrophil attractant/activation protein-1.
    J Immunol. 1990 Feb 15;144(4):1323-30 PMID: 2406341
  6. The neutrophil-activating peptide NAF/NAP-1 induces histamine and leukotriene release by interleukin 3-primed basophils.
    J Exp Med. 1989 Nov 1;170(5):1787-92 PMID: 2478657
  7. A novel cleavage product of beta-thromboglobulin formed in cultures of stimulated mononuclear cells activates human neutrophils.
    Biochem Biophys Res Commun. 1989 Mar 31;159(3):969-75 PMID: 2522778
  8. The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes.
    Science. 1989 Mar 17;243(4897):1464-6 PMID: 2648569
  9. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.
    J Clin Invest. 1989 Oct;84(4):1045-9 PMID: 2677047
  10. Chemiluminescence detection of H2O2 produced by human neutrophils during the respiratory burst.
    Anal Biochem. 1987 Sep;165(2):371-8 PMID: 3425906
  11. Interleukin-5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects.
    Blood. 1992 Jun 1;79(11):2952-9 PMID: 1316789
  12. Monocyte chemotactic and activating factor is a potent histamine-releasing factor for basophils.
    J Clin Invest. 1992 Mar;89(3):723-8 PMID: 1371775
  13. Airway eosinophils and lymphocytes in asthma. Birds of a feather?
    Am Rev Respir Dis. 1992 Jun;145(6):1246-8 PMID: 1375819
  14. Monocyte chemotactic protein 1 is a potent activator of human basophils.
    J Exp Med. 1992 May 1;175(5):1271-5 PMID: 1569397
  15. Effect of nerve growth factor on the release of inflammatory mediators by mature human basophils.
    Blood. 1992 May 15;79(10):2662-9 PMID: 1586715
  16. Modulation and induction of eosinophil chemotaxis by granulocyte-macrophage colony-stimulating factor and interleukin-3.
    Blood. 1991 Jun 15;77(12):2694-700 PMID: 1646045
  17. An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils.
    J Immunol Methods. 1991 Dec 15;145(1-2):105-10 PMID: 1662676
  18. T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma.
    J Immunol. 1991 Mar 15;146(6):1829-35 PMID: 1672334
  19. UCHL1+ (CD45RO+) 'memory' T cells predominate in the CD4+ cellular infiltrate associated with allergen-induced late-phase skin reactions in atopic subjects.
    Clin Exp Immunol. 1991 May;84(2):270-4 PMID: 1673877
  20. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES.
    Nature. 1990 Oct 18;347(6294):669-71 PMID: 1699135
  21. Interleukin 5 modifies histamine release and leukotriene generation by human basophils in response to diverse agonists.
    J Exp Med. 1990 Dec 1;172(6):1577-82 PMID: 1701820
  22. Biology of the RANTES/SIS cytokine family.
    Cytokine. 1991 May;3(3):165-83 PMID: 1715772
  23. Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin 8.
    J Exp Med. 1991 Dec 1;174(6):1355-62 PMID: 1744577
  24. CD4-mediated stimulation of human eosinophils: lymphocyte chemoattractant factor and other CD4-binding ligands elicit eosinophil migration.
    J Exp Med. 1991 Jun 1;173(6):1521-8 PMID: 1851800
  25. IL-3 and IL-5 prime normal human eosinophils to produce leukotriene C4 in response to soluble agonists.
    J Immunol. 1991 Dec 1;147(11):3855-61 PMID: 1940371
  26. Neutrophil-activating peptide 2 and gro/melanoma growth-stimulatory activity interact with neutrophil-activating peptide 1/interleukin 8 receptors on human neutrophils.
    J Biol Chem. 1991 Jun 5;266(16):10666-71 PMID: 2037605
  27. Lipopolysaccharide-stimulated human monocytes secrete, apart from neutrophil-activating peptide 1/interleukin 8, a second neutrophil-activating protein. NH2-terminal amino acid sequence identity with melanoma growth stimulatory activity.
    J Exp Med. 1990 Apr 1;171(4):1091-100 PMID: 2182761
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1992-12-01
Pages
1489-95
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2119467
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com